ovarian cancer

Research in Review

PARP-1 Measurement Guides Treatment Decisions in Ovarian Cancer

05/12/2017

JCP Editors

New research shows that blocking poly (ADP-ribose) polymerase-1 (PARP-1) may have a greater impact than restoring BRCA1 for the treatment of ovarian cancer, according to research presented at the 2017 American...

New...

05/12/2017

Journal of Clinical Pathways

Research in Review

Combination Therapy Effective in Treating Chemo-Resistant Ovarian Cancer

05/09/2017

JCP Editors

A combination regimen involving standard carboplatin chemotherapy and a novel drug may improve overall survival for more than 50% of women with high-grade serous ovarian cancers, according to research published in...

A...

05/09/2017

Journal of Clinical Pathways

Research in Review

Ovarian Cancer Survival Influenced By Previous Comorbidities

05/02/2017

JCP Editors

Common comorbidities such as hypertension, heart disease, and diabetes may contribute to a woman’s prognosis after being diagnosed with ovarian cancer, according to a study published in Cancer Causes Control...

Common...

05/02/2017

Journal of Clinical Pathways

Research in Review

Steep Increases in Genetic Test Cancellations Seen Following Mandated Genetic Counseling

12/13/2016

JCP Editors

Insurance-mandated genetic counseling prior to hereditary cancer genetic testing significantly increased test cancellation rates, particularly among minority patients, according to research published in Journal of...

...

12/13/2016

Journal of Clinical Pathways

Research in Review

NACT Spurs Immune Response in Patients With Ovarian Cancer

07/08/2016

JCP Editors

Administering immunotherapy immediately after chemotherapy may improve response when treating patients with stage IIIC-IV tubo-ovarian high-grade serous carcinoma, according to findings from a study published in...

...

07/08/2016

Journal of Clinical Pathways